Stephens Inc’s Cytosorbents Corp CTSO Stock Holding History

Stephens Inc’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-10,000	Closed	-$81K	–	1181
2018 Q4	$81K	Buy	+10,000	New	+$99.3K	﹤0.01%	1060

Other funds holding CTSO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

USAA

United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

Stephens Inc's CTSO Position: Q1 2019 in Review

Stephens Inc sold out of Cytosorbents Corp (CTSO) in Q1 2019, closing a stake of 10,000 shares — an estimated $81K sold.

Stephens Inc first reported a position in CTSO in Q4 2018 and held it in 1 quarter. The position peaked at $81K in Q4 2018. 77 funds tracked by Wall St. Rank hold CTSO as of Q1 2019.

Stephens Inc reported no remaining Cytosorbents Corp position as of Q1 2019 after selling out during the quarter.
Stephens Inc sold 10,000 Cytosorbents Corp shares in Q1 2019, an estimated $81K.
Stephens Inc first reported a position in Cytosorbents Corp in Q4 2018 and held it in 1 quarter.
Stephens Inc's Cytosorbents Corp position peaked at $81K in Q4 2018.
77 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2019.

Based on Stephens Inc's 13F filing for Q1 2019, filed 3 May 2019.